Related content

Clinical significance of IL-18, IL-15, IL-12 and TNF-α measurement in rheumatoid arthritis

By Petrovic-Rackov Ljiljana   Pejnovic Nada  

Clinical Rheumatology, Vol. 25, Iss. 4, 2006-07 ,pp. : 448-452

Springer Publishing Company

Access to resources Recommend Favorite

Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis

By Kageyama Yasunori   Takahashi Masaaki   Torikai Eiji   Suzuki Motohiro   Ichikawa Tetsuya   Nagafusa Tetsuyuki   Koide Yukio   Nagano Akira  

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 505-509

Springer Publishing Company

Access to resources Recommend Favorite

Radiographic progression of cervical lesions in patients with rheumatoid arthritis receiving infliximab treatment

By Kanayama Yasuhide   Kojima Toshihisa   Hirano Yuji   Shioura Tomone   Hayashi Masatoshi   Funahashi Koji   Ishiguro Naoki  

Modern Rheumatology, Vol. 20, Iss. 3, 2010-06 ,pp. : 273-279

Springer Publishing Company

Access to resources Recommend Favorite

A systematic review of the effect of TNF-α antagonists on lipid profiles in patients with rheumatoid arthritis

By Pollono Eduardo   Lopez-Olivo Maria   Lopez Juan   Suarez-Almazor Maria  

Clinical Rheumatology, Vol. 29, Iss. 9, 2010-09 ,pp. : 947-955

Springer Publishing Company

Access to resources Recommend Favorite

Reumacon (CPH82) showed similar x-ray progression and clinical effects as methotrexate in a two year comparative study on patients with early rheumatoid arthritis

By Svensson Björn   Pettersson Holger  

Scandinavian Journal of Rheumatology, Vol. 32, Iss. 2, 2003-01 ,pp. : 83-88

Informa Healthcare

Access to resources Recommend Favorite